Cancers
Frontiers in Cell-Cycle-Targeting Therapies: Addressing the Heterogeneity of the Cancer Cell Cycle.
Ishaar P Ganesan, Hiroaki Kiyokawa
Published: 202610.3390/cancers18020329
Abstract
The cell division cycle machinery has been regarded as a promising therapeutic target for several decades. One of the most prominent milestones in the approach to targeting the cancer cell cycle was the development and approval of CDK4/6 inhibitors s…
Preview only. Read the full abstract at the source